Bet_Noire
BMO Capital Markets has downgraded Q32 Bio (NASDAQ:QTTB) to market carry out from outperform following the corporate’s resolution to discontinue improvement of its drug ADX-097.
The agency famous that Q32 (NASDAQ:QTTB) determined to shelve ADX-097 to give attention to creating bempikibart
